Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
94 participants
OBSERVATIONAL
2021-11-05
2022-01-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants
NCT04144816
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
NCT06881953
Disease Burden of RSV
NCT05506670
Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV
NCT06197152
Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
NCT04944160
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Twins
Twins identified from the birth cohort (Hospices Civils de Lyon) with at least one twin hospitalized for an acute RSV-infection
Epidemiology
Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidemiology
Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one twin hospitalized with positive RSV-PCR during the first year of life
Exclusion Criteria
* Death of a twin before the RSV epidemic period of the first year of life
* Nosocomial infection
* Lack of understanding of the study or questionnaire by parents
* Lack of parental consent
354 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Femme-Mère-Enfant des Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL21_0634
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.